| Tag | Content |
|---|
EnhancerAtlas ID | HS139-23230 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr17:44089920-44091600 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| RORA | MA0071.1 | chr17:44090476-44090486 | TGACCTTGAT | - | 6.02 | | ZNF263 | MA0528.1 | chr17:44091573-44091594 | CTTTCCTCTTCTCTCTCCTCC | - | 7.56 | | ZNF263 | MA0528.1 | chr17:44091576-44091597 | TCCTCTTCTCTCTCCTCCTCT | - | 8.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_06294 | chr17:44089320-44092367 | Brain_Hippocampus_Middle |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 5 | Chromosome | Start | End |
| chr17 | 44090316 | 44090476 | | chr17 | 44090738 | 44091185 | | chr17 | 44090089 | 44090352 | | chr17 | 44090088 | 44090255 | | chr17 | 44090634 | 44090719 |
|
| | Number: 3 | ID | Chromosome | Start | End |
| GH17I046013 | chr17 | 44090644 | 44090750 | | GH17I046014 | chr17 | 44090832 | 44091101 | | GH17I046015 | chr17 | 44091281 | 44091510 |
|
Enhancer Sequence | CCCAGCCTGG GGGCCCCTTC CCAGCAGGCT GGCCCTGCTC CTTCTCTACC TGGGACCCTT 60
CTGCCTCCTG GCTGGACCCT GGAAGCTCTG CAGGGCCTGC TGTCCCCCTC CCTGCCCTCC 120
AGGTATCCTG ACCACCGGCC CTGGCTCCCA CTGCCATCCA CTCCTCTCCT TTCTGGCCGT 180
TCCCTGGTCC CTGTCCCAGC CCCCCTCCCC CTCTCACGAG TTACCTCACC CAGGCCAGAG 240
GGAAGAGGGA AGGAGGCCCT GGTCATACCA GCACGTCCTC CCACCTCCCT CGGCCCTGGT 300
CCACCCCCTC AGTGCTGGCC TCAGAGCACA GCTCTCTCCA AGCCAGGCCG CGCGCCATCC 360
ATCCTCCCTG TCCCCCAACG TCCTTGCCAC AGATCATGTC CGCCCTGACA CACATGGGTC 420
TCAGCCATCT CTGCCCCAGT TAACTCCCCA TCCATAAAGA GCACATGCCA GCTGACACCA 480
AAATAATTCG GGATGGTTCC AGTTTAGACC TAAGTGGAAG GAGAAACCAC CACCTGCCCT 540
GCACCTTGTT TTTTGGTGAC CTTGATAAAC CATCTTCAGC CATGAAGCCA GCTGTCTCCC 600
AGGAAGCTCC AGGGCGGTGC TTCCTCGGGA GCTGACTGAT AGGTGGGAGG TGGCTGCCCC 660
CTTGCACCCT CAGGTGACCC CACACAAGGC CACTGCTGGA GGCCCTGGGG ACTCCAGGAA 720
TGTCAATCAG TGACCTGCCC CCCAGGCCCC ACACAGCCAT GGCTGCATAG AGGCCTGCCT 780
CCAAGGGACC TGTCTGTCTG CCACTGTGGA GTCCCTACAG CGTGCCCCCC ACAGGGGAGC 840
TGGTTCTTTG ACTGAGATCA GCTGGCAGCT CAGGGTCATC ATTCCCAGAG GGAGCGGTGC 900
CCTGGAGGCC ACAGGCCTCC TCATGTGTGT CTGCGTCCGC TCGAGCTTAC TGAGACACTA 960
AATCTGTTGG TTTCTGCTGT GCCACCTACC CACCCTGTTG GTGTTGCTTT GTTCCTATTG 1020
CTAAAGACAG GAATGTCCAG GACACTGAGT GTGCAGGTGC CTGCTGGTTC TCACGTCCGA 1080
GCTGCTGAAC TCCGCTGGGT CCTGCTTACT GATGGTCTTT GCTCTAGTGC TTTCCAGGGT 1140
CCGTGGAAGC TTTTCCTGGA ATAAAGCCCA CGCATCGACC CTCACAGCGC CTCCCCTCTT 1200
TGAGGCCCAG CAGATACCCC ACTCCTGCCT TTCCAGCAAG ATTTTTCAGA TGCTGTGCAT 1260
ACTCATCATA TTGATCACTT TTTTCTTCAT GCCTGATTGT GATCTGTCAA TTTCATGTCA 1320
GGAAAGGGAG TGACATTTTT ACACTTAAGC GTTTGCTGAG CAAATGTCTG GGTCTTGCAC 1380
AATGACAATG GGTCCCTGTT TTTCCCAGAG GCTCTTTTGT TCTGCAGGGA TTGAAGACAC 1440
TCCAGTCCCA CAGTCCCCAG CTCCCCTGGG GCAGGGTTGG CAGAATTTCG ACAACACATT 1500
TTTCCACCCT GACTAGGATG TGCTCCTCAT GGCAGCTGGG AACCACTGTC CAATAAGGGC 1560
CTGGGCTTAC ACAGCTGCTT CTCATTGAGT TACACCCTTA ATAAAATAAT CCCATTTTAT 1620
CCTTTTTGTC TCTCTGTCTT CCTCTCTCTC TGCCTTTCCT CTTCTCTCTC CTCCTCTCTC 1680
|
